From Department of Interventional Radiology, No. 2 People's Hospital of Changzhou, Nanjing Medical University, Chang Zhou, China (Z.J.); Imaging Institute, Section of Interventional Radiology, Cleveland Clinic, OH (A.W.); Department of Radiology, Southend University Hospital, Essex, UK (M.T.); Department of Radiology, Wexner Medical Center at The Ohio State University, Columbus (J.S.); and Department of Radiology, Mayo Clinic, Jacksonville, FL (J.M.M., W.W.).
Circulation. 2015 Sep 8;132(10):944-52. doi: 10.1161/CIRCULATIONAHA.115.016468. Epub 2015 Jul 13.
Limited penetration into the caval wall is an important securing mechanism for inferior vena cava (IVC) filters; however, caval penetration can also cause unintentional complications. The aim of this study was to assess the incidence, severity, clinical consequences, and management of filter penetration across a range of commercially available IVC filters.
The MEDLINE database was searched for all studies (1970-2014) related to IVC filters. A total of 88 clinical studies and 112 case reports qualified for analysis; these studies included 9002 patients and 15 types of IVC filters. Overall, penetration was reported in 19% of patients (1699 of 9002), and 19% of those penetrations (322 of 1699) showed evidence of organ/structure involvement. Among patients with penetration, 8% were symptomatic, 45% were asymptomatic, and 47% had unknown symptomatology. The most frequently reported symptom was pain (77%, 108 of 140). Major complications were reported in 83 patients (5%). These complications required interventions including surgical removal of the IVC filter (n=63), endovascular stent placement or embolization (n=11), endovascular retrieval of the permanent filter (n=4), and percutaneous nephrostomy or ureteral stent placement (n=3). Complications led to death in 2 patients. A total of 87% of patients (127 of 146) underwent premature filter retrieval or interventions for underlying symptoms or penetration-related complications.
Caval penetration is a frequent but clinically underrecognized complication of IVC filter placement. Symptomatic patients accounted for nearly 1/10th of all penetrations; most of these cases had organ/structure involvement. Interventions with endovascular retrieval and surgery were required in most of these symptomatic patients.
下腔静脉(IVC)滤器有限穿透腔静脉壁是其重要的固定机制;然而,腔静脉穿透也可能导致意外并发症。本研究旨在评估各种市售 IVC 滤器的穿透发生率、严重程度、临床后果和管理。
检索 MEDLINE 数据库中所有与 IVC 滤器相关的研究(1970-2014 年)。共有 88 项临床研究和 112 例病例报告符合分析条件;这些研究包括 9002 例患者和 15 种 IVC 滤器。总体而言,19%的患者(9002 例中的 1699 例)报告有穿透,19%的穿透(1699 例中的 322 例)显示有器官/结构受累。在穿透患者中,8%有症状,45%无症状,47%未知症状。最常报告的症状是疼痛(77%,140 例中的 108 例)。83 例患者(5%)报告有严重并发症。这些并发症需要干预,包括 IVC 滤器的外科取出(n=63)、血管内支架置入或栓塞(n=11)、永久性滤器的血管内取回(n=4)和经皮肾造口术或输尿管支架置入(n=3)。并发症导致 2 例患者死亡。共有 146 例患者中的 127 例(87%)因潜在症状或穿透相关并发症而提前取出滤器或进行干预。
腔静脉穿透是 IVC 滤器放置的常见但临床认识不足的并发症。有症状的患者占所有穿透的近 1/10;这些病例大多有器官/结构受累。大多数有症状的患者需要血管内取回和手术干预。